Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey †

By Shiozawa Tomoo   Tadokoro Jun-ichi   Fujiki Toshitaka   Fujino Koji   Kakihata Koji   Masatani Shuji   Morita Satoshi   Gemma Akihiko   Boku Narikazu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 5, 2013-05 ,pp. : 483-491

Oxford University Press

Access to resources Recommend Favorite

Lung Cancer Chemotherapy, New Treatment and Related Patents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 3, 2014-09 ,pp. : 372-381

Bentham Science Publishers

Access to resources Recommend Favorite

Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer

By Akyurek Serap   Onal Cem   Cagar Aysun   Hicsonmez Ayse   Andrieu Meltem   Kurtman Cengiz  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 499-505

Humana Press, Inc

Access to resources Recommend Favorite

Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment

By Rubino C.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 1, 2002-09 ,pp. : 15-24

Springer Publishing Company

Access to resources Recommend Favorite

Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone

By Højris Inger   Andersen Jørn   Overgaard Marie   Overgaard Jens  

Acta Oncologica, Vol. 39, Iss. 3, 2000-10 ,pp. : 355-372

Informa Healthcare

Access to resources Recommend Favorite